Chart: FDA's September 2009 Report of Medical Device Approvals
This article was originally published in The Gray Sheet
FDA's September 2009 Report of Medical Device Approvals
You may also be interested in...
An item in FDA's Feb. 17 public listing of device recalls drew attention to Boston Scientific's recent move to rename its Taxus Liberté bare-metal coronary stent VeriFlex Bare-Metal. After hearing from cardiac cath labs that health care providers were inadvertently selecting Liberté bare-metal stents when the interventional cardiologist intended to implant a Liberté drug-eluting stent and vice-versa, the firm decided to rename the bare-metal version. In the recall, initiated last September, company reps visited all affected health care facilities and re-labeled the outer boxes of Liberté bare-metal stents to reflect the new name. The same month, FDA approved Boston Scientific's PMA supplement seeking to use the new trade name (1"The Gray Sheet" Nov. 2, 2009). Liberté paclitaxel-eluting stents continue to go by their original name
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.